Multimodal Non-Invasive Biomarker Characterization of Structural and Functional Alterations in ADSS1 Myopathy
Preprint
Abstract
Adenylosuccinate synthetase 1 (ADSS1) myopathy is an ultra-rare disease characterized by progressive muscle dysfunction. The objective of this investigation was to employ a non-invasive biomarker approach to phenotype (fine-)motor skills, speech production and cognition in adults with ADSS1 myopathy. Five individuals with ADSS1 myopathy and five age-sex-matched healthy controls (HCs) underwent a comprehensive multimodal evaluation. Assessments included, (i) evaluation of motor performance, (ii) speech production and cognitive test batteries, (iii) patient-reported outcomes, (iv) electrical impedance myography (EIM), (v) musculoskeletal magnetic resonance imaging (MRI) and (vi) plasma proteomics. ADSS1 participants vs. HCs demonstrated reduced performance on the 9-Hole Peg and grip strength tests as well as lower self-reported mobility. Speech production analysis revealed asthenia (p=0.02), lower intelligibility (p=0.008), and worse voice quality during the sustained vowel task (p=0.03) in the ADSS1 cohort. Cognitive functioning remained unaffected in patients with ADSS1. On EIM, ADSS1 participants vs. HCs, demonstrated a pattern of higher resistance and lower reactance and phase across upper- and lower-extremity measurements, indicative of poorer muscle health, with large effect sizes (Cliff’s 8=0.5-0.9). MRI revealed intramuscular fat infiltration, particularly in posterior compartments of the upper leg (e.g., biceps femoris). Proteomics indicated reduced (p=0.04) Neurotrophin-3 (NTF3; implicated in neuronal development, survival and differentiation) levels in the ADSS1 cohort relative to HCs. Lower NTF3 levels associated with poorer performance on hand-motor tasks as well as higher resistance and lower reactance and phase on EIM. This study highlighted the value of multimodal phenotyping for quantifying disease expression and advancing monitoring strategies in ADSS1 myopathy. Take-home message: This multimodal investigation demonstrates that integrating electrical impedance myography with quantitative motor, speech, musculoskeletal imaging, and proteomic assessments provides a sensitive and non-invasive research framework for capturing neuromuscular dysfunction and functional disease burden in patients with ADSS1 myopathy, thereby supporting the current biomarker strategy for refined phenotyping and longitudinal disease monitoring in this ultra-rare condition.Keywords
This publication has 43 references indexed in Scilit:
- Adenylosuccinate Synthase 1 Deficiency Improves Energy Metabolism by Promoting Adipose Tissue Re‐esterification via Glycerol Kinase UpregulationAdvanced Science, 2025
- A Multinational Study of Patient and Caregiver‐Reported Insights Into ADSS1 MyopathyMuscle & Nerve, 2025
- Variability in Disease Severity in Siblings With Homozygous Missense Variant of ADSSL1: Clinical Genetic Study and Review of LiteraturesMolecular Genetics & Genomic Medicine, 2024
- A pilot investigation of muscle integrity in patients with ADSSL1 myopathy using electrical impedance myographyMuscle & Nerve, 2023
- Home‐based biofeedback speech treatment improves dysarthria in repeat‐expansion SCAsAnnals of Clinical and Translational Neurology, 2022
- Electrical impedance myography for assessment of Duchenne muscular dystrophyAnnals of Neurology, 2017
- ADSSL1 mutation relevant to autosomal recessive adolescent onset distal myopathyAnnals of Neurology, 2015
- Grip and Knee extension muscle strength reflect a common construct among adultsMuscle & Nerve, 2012
- Electrical impedance myography in spinal muscular atrophy: A longitudinal studyMuscle & Nerve, 2011
- Is grip strength a predictor for total muscle strength in healthy children, adolescents, and young adults?European Journal of Pediatrics, 2009